📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
50
Warrant Exposure
50
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
35%
🔄 Reverse Split
55%
• 50-day avg $0.43 below $1 exchange minimum
📜 Warrant Exercise
25%
• Significant warrants: 16% of shares outstanding
💹 Market Data
Market Cap$22.76M
Shares Outstanding37.02M
Float17.21M
Cash$50.84M
Debt$37.24M
Short InterestN/A
🏛 Institutional Holdings
10 institutional holders · 2.70M shares
#1
Corient Private Wealth LLC
668.8K shares
#2
Vanguard Group Inc
478.6K shares
#3
Blackrock Inc.
420.1K shares
+ 7 more holders Sign up free to view →
📉 Short Interest
Short Interest2.35M
Days to Cover1.0
% of Float13.7%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2024
8-K
8K EVENT
May 04, 2026
13F-HR
BENEFICIAL OWNERSHIP
Mar 31, 2026
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for AGAE
📊 AGAE FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 AGAE Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.